RxDoctor Payments Data

Harneet Kaur

Physician Assistant · Garland, TXNPI 1346705845

Payments from drug & device makers

$3,383in general payments, 2019–2025

Across 168 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$575
  • Galderma Laboratories, L.p.$304
  • GSK$289
  • AstraZeneca$263
  • Novo Nordisk$211
  • Idorsia Pharmaceuticals US Inc$206
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$3,28397%
  • Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,383 in reported general payments places this provider in the 80th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$49,516
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$36,669
JardianceEmpagliflozin13$22,008
JanuviaSitagliptin Phosphate12$14,777
Breo ElliptaFluticasone/Vilanterol16$8,309
PaxlovidNirmatrelvir/Ritonavir22$4,359
Albuterol Sulfate HfaAlbuterol Sulfate75$1,930
Omeprazole79$1,786
Gabapentin80$1,699
Rosuvastatin Calcium153$1,663
Atorvastatin Calcium170$1,457
Amlodipine Besylate203$1,363
Bupropion XlBupropion Hcl26$1,294
Tizanidine Hcl105$1,248
Duloxetine Hcl27$1,208

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$61$53,87562 claims
GSKTrelegy Ellipta, Breo Ellipta$289$44,97841 claims
MerckJanuvia$67$14,77712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Garland

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →